Shareholders’ Equity (Details) - USD ($) $ / shares in Units, $ in Thousands |
|
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
12 Months Ended |
|
|
|
Jul. 31, 2025 |
Mar. 19, 2025 |
Oct. 02, 2023 |
Nov. 09, 2021 |
Mar. 29, 2021 |
Feb. 18, 2021 |
Feb. 11, 2021 |
Feb. 09, 2021 |
Jan. 15, 2021 |
Jan. 07, 2021 |
Dec. 22, 2020 |
Feb. 24, 2021 |
Dec. 31, 2025 |
Aug. 11, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares authorized (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
|
6,000,000,000
|
|
6,000,000,000
|
|
| Ordinary shares, par value |
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.75
|
|
$ 0.75
|
|
| Exercise price |
$ 3.5
|
$ 222,337,500
|
|
|
|
|
|
|
|
$ 5.55
|
|
|
|
|
|
|
| Warrant description |
|
|
|
|
|
|
|
|
|
|
|
|
The
February Inducement Warrants have substantially the same terms as the January Inducement Warrants, except for having (i) registration
rights whereby the Company agreed to register the ADSs underlying the February Inducement Warrants within twenty-one (21) days of closing,
and (ii) an exercise price of $4.05 per ADS.
|
|
|
|
| Share of the Company, par value |
|
5.2
|
$ 4.57
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Price per unit |
|
$ 0.034666
|
$ 0.45655
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate purchase price of offering (in Dollars) |
|
$ 7,700
|
$ 17,880
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Registered Direct Offering in December 2020 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
$ 4.65
|
|
|
|
|
|
| January 2021 Warrant Solicitation [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant description |
|
|
|
|
|
|
|
|
|
|
|
|
The
January Inducement Warrants have substantially the same terms as the Existing Warrants, except for having (i) provisions customary for
an unregistered warrant, including a restrictive legend, (ii) registration rights whereby the Company agreed to register the ADSs underlying
the January Inducement Warrants within fifteen (15) days of closing, (iii) being exercisable immediately upon issuance, (iv) having a
term of five (5) years from the date of issuance, and (v) having an exercise price of $2.00 per ADS.
|
|
|
|
| February 2021 Warrant Solicitations [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant description |
|
|
|
|
|
|
|
|
|
|
|
|
The
Second February Inducement Warrants have substantially the same terms as the February Inducement Warrants, except for having (i) registration
rights whereby the Company agrees to register the ADSs underlying the Second February Inducement Warrants within eight (8) days of closing,
and (ii) an exercise price $7.00 per ADS.
|
|
|
|
| Registered Direct Offerings in February 2021 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrant (in Shares) |
|
|
|
|
25,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
$ 30
|
$ 15
|
|
|
|
|
|
|
|
|
|
| Ordinary Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares authorized (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
|
6,000,000,000
|
|
|
|
| ADS [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock number of shares (in Shares) |
2,142,855
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
$ 3.5
|
$ 0.0398
|
$ 0.57069
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants (in Shares) |
4,285,710
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share of the Company, par value |
|
0.005
|
0.005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Price per unit |
|
$ 5.97
|
$ 5.71
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Securities Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock number of shares (in Shares) |
|
|
39,171,620
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| November Spa [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock number of shares (in Shares) |
|
|
|
51,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds (in Dollars) |
|
|
|
$ 90,100
|
|
|
|
|
|
|
|
|
|
|
|
|
| Securities Purchase Agreement [Member] | Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrants (in Shares) |
|
|
|
|
25,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Securities Purchase Agreement [Member] | Registered Direct Offering in December 2020 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock number of shares (in Shares) |
|
|
|
|
|
|
|
|
|
|
2,600,000
|
|
|
|
|
|
| Purchase of warrant (in Shares) |
|
|
|
|
|
|
|
|
|
|
2,600,000
|
|
|
|
|
|
| Gross proceeds from warrants (in Dollars) |
|
|
|
|
|
|
|
|
|
|
$ 4,000
|
|
|
|
|
|
| Issuance for period term |
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
$ 1.55
|
|
|
|
|
|
| Purchase per share price |
|
|
|
|
|
|
|
|
|
|
$ 1.55
|
|
|
|
|
|
| Securities Purchase Agreement [Member] | Registered Direct Offering in January 2021 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock number of shares (in Shares) |
|
|
|
|
|
|
|
|
|
13,525,000
|
|
|
|
|
|
|
| Purchase of warrant (in Shares) |
|
|
|
|
|
|
|
|
|
13,525,000
|
|
|
|
|
|
|
| Gross proceeds from warrants (in Dollars) |
|
|
|
|
|
|
|
|
|
$ 25,000
|
|
|
|
|
|
|
| Issuance for period term |
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
$ 1.85
|
|
|
|
|
|
|
| Purchase per share price |
|
|
|
|
|
|
|
|
|
$ 1.85
|
|
|
|
|
|
|
| Securities Purchase Agreement [Member] | January 2021 Warrant Solicitation [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrant (in Shares) |
|
|
|
|
|
|
|
|
14,925,000
|
|
|
|
|
|
|
|
| Unexercised existing warrants (in Dollars) |
|
|
|
|
|
|
|
|
$ 27,100
|
|
|
|
|
|
|
|
| Securities Purchase Agreement [Member] | January Inducement Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrant (in Shares) |
|
|
|
|
|
|
|
|
23,880,000
|
|
|
|
|
|
|
|
| Securities Purchase Agreement [Member] | February 2021 Warrant Solicitations [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrant (in Shares) |
|
|
|
|
|
|
|
23,880,000
|
|
|
|
23,880,000
|
|
|
|
|
| Gross proceeds from warrants (in Dollars) |
|
|
|
|
|
|
|
$ 48,000
|
|
|
|
$ 96,700
|
|
|
|
|
| Exchange for exercise warrant (in Shares) |
|
|
|
|
|
|
|
23,880,000
|
|
|
|
|
|
|
|
|
| Securities Purchase Agreement [Member] | Second February Inducement Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrant (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
23,880,000
|
|
|
|
|
| Securities Purchase Agreement [Member] | Registered Direct Offerings in February 2021 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock number of shares (in Shares) |
|
|
|
|
|
8,600,000
|
22,000,000
|
|
|
|
|
|
|
|
|
|
| Purchase of warrant (in Shares) |
|
|
|
|
|
4,300,000
|
16,500,000
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from warrants (in Dollars) |
|
|
|
|
|
$ 86,000
|
$ 110,000
|
|
|
|
|
|
|
|
|
|
| Issuance for period term |
|
|
|
|
|
5 years
|
5 years
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
$ 10
|
$ 5
|
|
|
|
|
|
|
|
|
|
| Purchase per share price |
|
|
|
|
|
$ 10
|
$ 5
|
|
|
|
|
|
|
|
|
|
| Class A Ordinary Shares[Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
|
13,235,873
|
|
2,964,518
|
6,099,608,450
|
| Class A Ordinary Shares[Member] | Registered Direct Offerings in February 2021 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase ordinary shares (in Shares) |
|
|
|
|
250,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Class A Ordinary Shares[Member] | Ordinary Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
| Class A Ordinary Shares[Member] | Securities Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares (in Shares) |
|
|
|
|
250,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Common Class B [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
|
2,934,447
|
|
163,210
|
698,562,525
|
| Common Class B [Member] | Ordinary Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
| Ordinary shares (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
|
2,737,877
|
|
|
|
| Common Class B [Member] | Extraordinary General Meeting [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued (in Shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
500,000,000
|
|
|
| Class B Ordinary Shares [Member] | Extraordinary General Meeting [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.005
|
|
|